Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
The local literature lacks comprehensive information regarding the actual incidence of intrauterine growth restriction (IUGR) and oligohydramnios and currently available therapeutic options. Therefore, the current study was planned with the objective to evaluate the impact of enoxaparin therapy compared with standard management on neonatal outcomes in pregnancies complicated by intrauterine growth restriction (IUGR) with oligohydramnios.
Epistemonikos ID: 0666ce21740317384c4fe4d0ebbc30ff8678ce34
First added on: Mar 11, 2026